784 Immune Profiling of Patients with Advanced Melanoma Intratumorally Treated with CV8102 As a Single-Agent or in Combination with Anti-Pd-1 Antibodies – Results of a Phase I Trial Expansion
Regular and Young Investigator Award Abstracts（2022）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined